Basic Fibroblast Growth Factor Increases the Number of Endogenous Neural Stem Cells and Inhibits the Expression of Amino Methyl Isoxazole Propionic Acid Receptors in Amyotrophic Lateral Sclerosis Mice

Overview

Journal Neural Regen Res

Date 2015 Mar 5

PMID 25737699

Citations 1

Authors

Weihui Huang

Dawei Zang

Yi Lu

Ping Jiang

Affiliations

Soon will be listed here.

Abstract

This study aimed to investigate the number of amino methyl isoxazole propionic acid (AMPA) receptors and production of endogenous neural stem cells in the SOD1(G93AG1H) transgenic mouse model of amyotrophic lateral sclerosis, at postnatal day 60 following administration of basic fibroblast growth factor (FGF-2). A radioligand binding assay and immunohistochemistry were used to estimate the number of AMPA receptors and endogenous neural stem cells respectively. Results showed that the number of AMPA receptors and endogenous neural stem cells in the brain stem and sensorimotor cortex were significantly increased, while motor function was significantly decreased at postnatal days 90 and 120. After administration of FGF-2 into mice, numbers of endogenous neural stem cells increased, while expression of AMPA receptors decreased, whilst motor functions were recovered. At postnatal day 120, the number of AMPA receptors was negatively correlated with the number of endogenous neural stem cells in model mice and FGF-2-treated mice. Our experimental findings indicate that FGF-2 can inhibit AMPA receptors and increase the number of endogenous neural stem cells, thus repairing neural injury in amyotrophic lateral sclerosis mice.

Citing Articles

Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach.

Morello G, Spampinato A, Conforti F, DAgata V, Cavallaro S J Mol Neurosci. 2017; 61(4):563-580.

PMID: 28236105 PMC: 5359376. DOI: 10.1007/s12031-017-0898-9.

References

Zang D, Yang Q, Wang H, Egan G, Lopes E, Cheema S . Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci. 2004; 20(7):1745-51. DOI: 10.1111/j.1460-9568.2004.03648.x. View

Coutu D, Galipeau J . Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging (Albany NY). 2011; 3(10):920-33. PMC: 3229969. DOI: 10.18632/aging.100369. View

Kwak S, Hideyama T, Yamashita T, Aizawa H . AMPA receptor-mediated neuronal death in sporadic ALS. Neuropathology. 2010; 30(2):182-8. DOI: 10.1111/j.1440-1789.2009.01090.x. View

Henley J, Barker E, Glebov O . Routes, destinations and delays: recent advances in AMPA receptor trafficking. Trends Neurosci. 2011; 34(5):258-68. PMC: 3314507. DOI: 10.1016/j.tins.2011.02.004. View

Martino G, Pluchino S, Bonfanti L, Schwartz M . Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev. 2011; 91(4):1281-304. PMC: 3552310. DOI: 10.1152/physrev.00032.2010. View

Turner B, Atkin J, Farg M, Zang D, Rembach A, Lopes E . Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci. 2005; 25(1):108-17. PMC: 6725218. DOI: 10.1523/JNEUROSCI.4253-04.2005. View

Lai W, Krishnappa V, Phinney D . Fibroblast growth factor 2 (Fgf2) inhibits differentiation of mesenchymal stem cells by inducing Twist2 and Spry4, blocking extracellular regulated kinase activation, and altering Fgf receptor expression levels. Stem Cells. 2011; 29(7):1102-11. PMC: 3410557. DOI: 10.1002/stem.661. View

Peng P, Zhong X, Tu W, Soundarapandian M, Molner P, Zhu D . ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia. Neuron. 2006; 49(5):719-33. DOI: 10.1016/j.neuron.2006.01.025. View

Liu J, Zang D . Response of neural precursor cells in the brain of Parkinson's disease mouse model after LIF administration. Neurol Res. 2008; 31(7):681-6. DOI: 10.1179/174313209X382368. View

10.

Kalra S, Arnold D, Cashman N . Biological markers in the diagnosis and treatment of ALS. J Neurol Sci. 1999; 165 Suppl 1:S27-32. DOI: 10.1016/s0022-510x(99)00023-4. View

11.

Liu S, Lau L, Wei J, Zhu D, Zou S, Sun H . Expression of Ca(2+)-permeable AMPA receptor channels primes cell death in transient forebrain ischemia. Neuron. 2004; 43(1):43-55. DOI: 10.1016/j.neuron.2004.06.017. View

12.

Lee H, Kirkwood A . AMPA receptor regulation during synaptic plasticity in hippocampus and neocortex. Semin Cell Dev Biol. 2011; 22(5):514-20. PMC: 3190053. DOI: 10.1016/j.semcdb.2011.06.007. View

13.

Zang D, Lopes E, Cheema S . Loss of synaptophysin-positive boutons on lumbar motor neurons innervating the medial gastrocnemius muscle of the SOD1G93A G1H transgenic mouse model of ALS. J Neurosci Res. 2005; 79(5):694-9. DOI: 10.1002/jnr.20379. View

14.

Zang D, Cheema S . Degeneration of corticospinal and bulbospinal systems in the superoxide dismutase 1(G93A G1H) transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett. 2002; 332(2):99-102. DOI: 10.1016/s0304-3940(02)00944-8. View

15.

Juan L, Dawei Z, Julie A . Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1(G93A) (G1H) transgenic mouse model of amyotrophic lateral sclerosis. Neurol Res. 2007; 29(2):204-9. DOI: 10.1179/174313206X152519. View